NCT01186614

Brief Summary

Sudden out-of-hospital cardiac arrest (OHCA) is a leading cause of death in Australia. The most common cause of OHCA is a heart attack. The current treatment of OHCA is resuscitation by ambulance paramedics involving CPR, electrical shocks to the heart, and injections of adrenaline. In more than 50% of cases, paramedics are unable to start the heart and the patient is declared dead at the scene. Patients with OHCA who do not respond to paramedic resuscitation are not routinely transported to hospital because it is hazardous for paramedics to undertake rapid transport whilst administering chest compressions and there is currently no additional therapy available at the hospital that would assist in starting the heart. However, a number of recent developments suggest that there may be a new approach to the resuscitation of this group of patients who would otherwise die. Firstly, Ambulance Victoria have recently introduced portable battery powered machines that allow chest compressions to be safely and effectively delivered during emergency ambulance transport. Second, The Alfred ICU will shortly be implementing a new protocol whereby the patient in cardiac arrest can immediately be placed on a heart-lung machine. This is known as extra-corporeal membrane oxygenation (ECMO). Third, the brain can now be much better protected against damage due to lack of blood flow using therapeutic hypothermia which is the controlled lowering of body temperature from 37°C to 33°C. Clinical trials have demonstrated that this significantly decreases brain damage after OHCA. Finally, The Alfred Cardiology service has an emergency service for reopening the blocked artery of the heart in patients who present with a sudden blockage of the heart arteries. This is currently not used in patients without a heart beat because of the technical difficulty of undertaking this procedure with chest compressions being undertaken. This study proposes for the first time to implement all the above interventions when patients have failed standard resuscitation after OHCA. When standard resuscitation has proved futile, the patient will be transported to The Alfred with the mechanical chest compression device, cooled to 33°C, placed on ECMO, and then transported to the interventional cardiac catheter laboratory. The patient will then receive therapeutic hypothermia for 24 hours. Subsequent management will follow the standard treatment guidelines of The Alfred Intensive Care Unit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Nov 2010

Longer than P75 for phase_1

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 23, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

March 10, 2014

Status Verified

March 1, 2014

Enrollment Period

3.7 years

First QC Date

August 20, 2010

Last Update Submit

March 6, 2014

Conditions

Keywords

cardiac arrestECMOhypothermiaautomated CPRcoronary intervention

Outcome Measures

Primary Outcomes (1)

  • Survival to hospital discharge

    At hospital discharge

Secondary Outcomes (4)

  • Neurologic recovery

    At discharge

  • Time until ECMO insertion

    On admission

  • neurologic biomarkers

    Day 3

  • Cardiac recovery

    Days 1, 3, 5

Study Arms (1)

Novel treatment paradigm

EXPERIMENTAL

treatment protocol including - mechanical CPR, therapeutic hypothermia, ECMO, coronary intervention

Device: Automated CPRDevice: ECMOProcedure: Coronary angiographyProcedure: Therapeutic Hypothermia

Interventions

Automated CPR utilised by paramedics to facilitate CPR during transport to hospital

Also known as: Zoll Autopulse
Novel treatment paradigm
ECMODEVICE

Insertion of peripheral VA ECMO

Novel treatment paradigm

Coronary angiography and intervention where necessary will be performed following ECMO insertion

Novel treatment paradigm

Paramedic initiated hypothermia with intravenous ice cold fluid and then continued for 24 hours (33 degrees)

Novel treatment paradigm

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults 18-59 years
  • Out of hospital cardiac arrest due to presumed cardiac caus
  • Chest compressions are commenced within 10 minutes by bystanders or emergency medical services
  • Initial cardiac arrest rhythm of ventricular fibrillation
  • Remains in cardiac arrest at the scene at 20 minutes after standard paramedic advanced cardiac life support (intubation, intravenous adrenaline)
  • Autopulse machine is available
  • Within 10 minutes ambulance transport time to The Alfred
  • During normal working hours (9am-5pm, Monday to Friday)
  • ECMO commences within 60 minutes of the initial collapse

You may not qualify if:

  • Presumed non-cardiac cause of cardiac arrest such as trauma, hanging, drowning, intracranial bleeding
  • Any pre-existing significant neurological disability
  • Significant non-cardiac co-morbidities that cause limitations in activities of daily living such as COPD, cirrhosis of the liver, renal failure on dialysis, terminal illness due to malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Alfred Hospital

Melbourne, Victoria, 3161, Australia

RECRUITING

Ambulance Victoria

Melbourne, Victoria, Australia

NOT YET RECRUITING

MeSH Terms

Conditions

Heart ArrestHypothermia

Interventions

Hypothermia, Induced

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CryotherapyTherapeutics

Study Officials

  • Stephen A Bernard, MBBS MD

    The Alfred

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephen A bernard, MBBS MD

CONTACT

Dion A Stub, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research and Ethics Unit

Study Record Dates

First Submitted

August 20, 2010

First Posted

August 23, 2010

Study Start

November 1, 2010

Primary Completion

July 1, 2014

Study Completion

December 1, 2014

Last Updated

March 10, 2014

Record last verified: 2014-03

Locations